We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$1.79B
(+14%)
Cap. Flow
+$849M
Cap. Flow
% of AUM
5.76%
Top 10 Holdings %
Top 10 Hldgs %
16.89%
Holding
1,178
New
178
Increased
473
Reduced
324
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$128M |
| 2 |
Intel
INTC
|
+$88.4M |
| 3 |
Prudential Financial
PRU
|
+$72.7M |
| 4 |
Lam Research
LRCX
|
+$62.6M |
| 5 |
SBA Communications
SBAC
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$98.3M |
| 2 |
Target
TGT
|
+$86.8M |
| 3 |
Occidental Petroleum
OXY
|
+$74.7M |
| 4 |
Synchrony
SYF
|
+$61.6M |
| 5 |
Intercontinental Exchange
ICE
|
+$57.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.69% |
| 2 | Healthcare | 13.54% |
| 3 | Financials | 13.08% |
| 4 | Consumer Discretionary | 12.97% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Polaris
PII
$4.07B
| $4.11M | 0.03% |
29,987
-45,566
| -60% | -$6.18M |
|
|
RYZ
477
Ryerson Holding Corp
RYZ
$1.61B
| $4.1M | 0.03% |
281,033
+11,098
| +4% | +$175K |
|
478
Universal Insurance Holdings
UVE
$1.23B
| $4.09M | 0.03% |
294,502
+6,024
| +2% | +$84.6K |
|
|
IVC
479
DELISTED
Invacare Corporation
IVC
| $4.07M | 0.03% |
504,006
+200,390
| +66% | +$1.67M |
|
|
LCI
480
DELISTED
Lannett Company, Inc.
LCI
| $4.05M | 0.03% |
216,914
+92,989
| +75% | +$1.78M |
|
481
REX American Resources
REX
$1.4B
| $4.01M | 0.03% |
266,796
+10,968
| +4% | +$160K |
|
482
Forestar Group
FOR
$1.5B
| $3.97M | 0.03% |
189,881
+141,892
| +296% | +$3.32M |
|
483
Entravision Communication
EVC
$1.01B
| $3.96M | 0.03% |
593,541
+307,331
| +107% | +$1.39M |
|
484
Silicon Laboratories
SLAB
$7.17B
| $3.91M | 0.03% |
25,517
-7,498
| -23% | -$1.05M |
|
485
Phathom Pharmaceuticals
PHAT
$930M
| $3.9M | 0.03% |
+115,339
| New | +$4.13M |
|
486
Dana Inc
DAN
$2.95B
| $3.86M | 0.03% |
162,523
+17,947
| +12% | +$465K |
|
487
Amphastar Pharmaceuticals
AMPH
$888M
| $3.83M | 0.03% |
190,077
+65,847
| +53% | +$1.24M |
|
488
Gogo Inc
GOGO
$550M
| $3.79M | 0.03% |
333,440
-41,491
| -11% | -$480K |
|
489
QCR Holdings
QCRH
$1.69B
| $3.79M | 0.03% |
78,865
+3,465
| +5% | +$166K |
|
490
Lincoln National
LNC
$8.19B
| $3.7M | 0.03% |
+58,810
| New | +$3.88M |
|
491
UNIFI
UFI
$121M
| $3.69M | 0.03% |
151,498
-4,914
| -3% | -$131K |
|
492
Highwoods Properties
HIW
$3.71B
| $3.68M | 0.03% |
81,511
+7,050
| +9% | +$317K |
|
493
ABM Industries
ABM
$2.88B
| $3.67M | 0.02% |
82,812
-253
| -0.3% | -$12.7K |
|
|
PSTX
494
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $3.65M | 0.02% |
364,171
-20,645
| -5% | -$185K |
|
|
TCDA
495
DELISTED
Tricida, Inc. Common Stock
TCDA
| $3.64M | 0.02% |
842,126
+150,875
| +22% | +$719K |
|
496
Atmos Energy
ATO
$29.9B
| $3.59M | 0.02% |
+37,379
| New | +$3.75M |
|
|
FL
497
DELISTED
Foot Locker
FL
| $3.53M | 0.02% |
+57,350
| New | +$3.47M |
|
|
UBX
498
DELISTED
Unity Biotechnology
UBX
| $3.53M | 0.02% |
75,992
+18,448
| +32% | +$888K |
|
499
Barrett Business Services
BBSI
$1.01B
| $3.52M | 0.02% |
194,052
-120,988
| -38% | -$2.22M |
|
500
Jefferies Financial Group
JEF
$13.2B
| $3.52M | 0.02% |
+107,566
| New | +$3.28M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2021 Portfolio in Review
As of Q2 2021, Jacobs Levy Equity Management held 1,178 positions worth $14.8B, up 14% from $13B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $849M of net new capital in Q2 2021, opening 178 new positions and adding to 473 existing holdings. Its largest new stake was Lam Research: 991,120 shares worth $64.5M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Qualcomm, an estimated $98.3M trimmed.
- Jacobs Levy Equity Management's largest Q2 2021 buy was Lam Research: 991,120 shares worth $64.5M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q2 2021, an estimated $128M increase.
- Jacobs Levy Equity Management's biggest Q2 2021 reduction was Qualcomm, cutting an estimated $98.3M.
- Jacobs Levy Equity Management fully exited Occidental Petroleum in Q2 2021, selling an estimated $74.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q2 2021.
- Jacobs Levy Equity Management opened 178 new positions and closed 161 in Q2 2021.
- Jacobs Levy Equity Management's portfolio value rose 14% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2021, filed 16 Aug 2021.